• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5073089)   Today's Articles (92)
For: Cassinello Espinosa J, González Del Alba Baamonde A, Rivera Herrero F, Holgado Martín E. SEOM guidelines for the treatment of bone metastases from solid tumours. Clin Transl Oncol 2012;14:505-11. [PMID: 22721794 DOI: 10.1007/s12094-012-0832-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Number Cited by Other Article(s)
1
Reginelli A, Patanè V, Urraro F, Russo A, De Chiara M, Clemente A, Atripaldi U, Balestrucci G, Buono M, D’ippolito E, Grassi R, D’onofrio I, Napolitano S, Troiani T, De Vita F, Ciardiello F, Nardone V, Cappabianca S. Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study). Diagnostics (Basel) 2023;13:2334. [PMID: 37510078 PMCID: PMC10378594 DOI: 10.3390/diagnostics13142334] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 06/23/2023] [Accepted: 06/29/2023] [Indexed: 07/30/2023]  Open
2
Matuoka JY, Kahn JG, Secoli SR. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2019;20:487-499. [PMID: 30382484 DOI: 10.1007/s10198-018-1011-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Accepted: 10/23/2018] [Indexed: 06/08/2023]
3
Cheung FY. Revisiting the role of bone-modifying agents in the management of metastatic prostate cancer. Asia Pac J Clin Oncol 2018;14 Suppl 5:13-15. [DOI: 10.1111/ajco.13061] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
4
Huang SM, Yang JJ, Chen HJ, Wu SP, Bai XY, Zhou Q, Tu HY, Wu YL. Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer. Oncotarget 2017;8:81369-81376. [PMID: 29113396 PMCID: PMC5655291 DOI: 10.18632/oncotarget.18759] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Accepted: 05/15/2017] [Indexed: 02/04/2023]  Open
5
Kim SY, Ok HG, Birkenmaier C, Kim KH. Can denosumab be a substitute, competitor, or complement to bisphosphonates? Korean J Pain 2017;30:86-92. [PMID: 28416991 PMCID: PMC5392661 DOI: 10.3344/kjp.2017.30.2.86] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2017] [Revised: 03/09/2017] [Accepted: 03/10/2017] [Indexed: 12/17/2022]  Open
6
Khalafallah AA, Slancar M, Cosolo W, Abdi E, Chern B, Woodfield RJ, Copeman MC. Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study. Eur J Cancer Care (Engl) 2017;27:e12638. [PMID: 28134499 PMCID: PMC5901400 DOI: 10.1111/ecc.12638] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/05/2016] [Indexed: 11/30/2022]
7
SEOM Clinical Guideline for bone metastases from solid tumours (2016). Clin Transl Oncol 2016;18:1243-1253. [PMID: 27896639 PMCID: PMC5138247 DOI: 10.1007/s12094-016-1590-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Accepted: 11/18/2016] [Indexed: 12/25/2022]
8
De Castro J, García R, Garrido P, Isla D, Massuti B, Blanca B, Vázquez J. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications. Clin Lung Cancer 2015;16:431-46. [PMID: 26264596 DOI: 10.1016/j.cllc.2015.06.004] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Revised: 06/09/2015] [Accepted: 06/16/2015] [Indexed: 12/29/2022]
9
Pandit S, Das A, Das SK, Choudhury S, Mukherjee S. A rare case of sternal erosion due to bronchogenic carcinoma. Ethiop J Health Sci 2014;24:89-92. [PMID: 24591804 PMCID: PMC3929933 DOI: 10.4314/ejhs.v24i1.12] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
10
Rolfo C, Raez LE, Russo A, Reguart N, Campelo RG, Bronte G, Papadimitriou K, Silvestris F. Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor. Expert Opin Biol Ther 2013;14:15-26. [PMID: 24161019 DOI: 10.1517/14712598.2013.843667] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
11
Llombart Cussac A, de la Haba Rodríguez J, Ruiz Simón A, Álvarez López I, Cortés Castán J. SEOM clinical guidelines for the management of metastatic breast cancer 2013. Clin Transl Oncol 2013;15:1004-10. [PMID: 24151043 DOI: 10.1007/s12094-013-1095-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2013] [Accepted: 07/22/2013] [Indexed: 12/22/2022]
12
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey. J Bone Oncol 2013;2:105-9. [PMID: 26909279 PMCID: PMC4723402 DOI: 10.1016/j.jbo.2013.05.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2013] [Accepted: 05/27/2013] [Indexed: 11/22/2022]  Open
13
Hutton B, Addison C, Mazzarello S, Joy AA, Bouganim N, Fergusson D, Clemons M. De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists. J Bone Oncol 2013;2:77-83. [PMID: 26909274 PMCID: PMC4723366 DOI: 10.1016/j.jbo.2013.03.001] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2013] [Revised: 03/25/2013] [Accepted: 03/26/2013] [Indexed: 02/05/2023]  Open
14
SEOM clinical guidelines: a consolidated project. Clin Transl Oncol 2012;14:489-90. [DOI: 10.1007/s12094-012-0829-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA